Abstract:Reshma, A. ; Subramanian, A. ; Kumarasamy, V. ; Tamilanban, T. ; Sekar, M. ; Gan, S.h. ; Subramaniyan, V. ; Wong, L.s. ; Rani, N.n.i.m. ; Wu, Y.s. ; Cognitive disorders and dementia largely influence individual independence and orientation. Based on the Alzheimer's Disease International (ADI) estimation, approximately 75% of individuals with dementia are undiagnosed. In fact, in some low- and middle-income countries, the percentage is as high as 90%. In this systematic review, which is based on PRISMA guidelines, we aim to identify the mechanism of action of proanthocyanidin. Finding a natural product alternative as a potential nootropic can help increase the number of armamentariums against dementia and other cognitive impairments. In this preclinical research, we determined the effect of proanthocyanidins on Alzheimer's disease (AD) by searching electronic bibliographic databases like Scopus, Proquest, ScienceDirect, PubMed, and Google. There was no imposed time limit. However, the search was limited to only English articles. The review protocol is registered on PROSPERO as CRD42022356301. A population, intervention, control, and outcomes (PICO) technique was utilized for report inclusion, and all reports were assessed for risk of bias by using the SYRCLE's RoB tool. The article's bibliographic information, induction model, type of proanthocyanidins, animal strain/weight/age, and outcome measurements were acquired from ten papers and are reported here. Further analysis was validated and determined for the review. The included studies met the review's inclusion criteria and suggested that proanthocyanidins have a neurocognitive effect against AD. Additionally, the effectiveness of proanthocyanidins in reducing oxidative stress, acetylcholinesterase activity, amyloid beta, its efficacy in alleviating superoxide dismutase, cognitive properties, and in facilitating cholinergic transmission in various models of AD has been collectively observed in ten studies.

Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer's disease

Research Progress on Alzheimer's Disease and Resveratrol

Resveratrol As A Therapeutic Agent for Alzheimer'S Disease

Resveratrol Mediated Regulation of Hippocampal Neuroregenerative Plasticity via SIRT1 Pathway in Synergy with Wnt Signaling: Neurotherapeutic Implications to Mitigate Memory Loss in Alzheimer's Disease

Resveratrol as a therapeutic agent for Alzheimer's disease.

Effects and safety of resveratrol supplementation in older adults: A comprehensive systematic review

Resveratrol and Alzheimer's Disease: Mechanistic Insights

Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases

Resveratrol As a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer’s Disease

Unraveling the therapeutic efficacy of resveratrol in Alzheimer's disease: an umbrella review of systematic evidence

Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside

Antioxidant Properties of Resveratrol and its Protective Effects in Neurodegenerative Diseases

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease

The Effect of Resveratrol on Neurodegenerative Disorders: Possible Protective Actions Against Autophagy, Apoptosis, Inflammation and Oxidative Stress

Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy

Neurocognitive effects of proanthocyanidin in Alzheimer's disease: a systematic review of preclinical evidence

Resveratrol-Selenium Nanoparticles Alleviate Neuroinflammation and Neurotoxicity in a Rat Model of Alzheimer’s Disease by Regulating Sirt1/miRNA-134/GSK3β Expression

Development, Statistical Optimization, and Characterization of Resveratrol‐Containing Solid Lipid Nanoparticles (SLNs) and Determination of the Efficacy in Reducing Neurodegenerative Symptoms Related to Alzheimer's Disease: In Vitro and In Vivo Study

How efficient is resveratrol as an antioxidant of the Mediterranean diet, towards alterations during the aging process?

Improving effect of chronic resveratrol treatment on central monoamine synthesis and cognition in aged rats

Neuroprotective Effect of Resveratrol via Activation of Sirt1 Signaling in a Rat Model of Combined Diabetes and Alzheimer's Disease.